Page 37 - 72_04
P. 37
VOL. 72 (4), 583-598, 2006 EL HIPÉRICO: UNA FUENTE DE COMPUESTOS...
(21) SINGER, A.; WONNEMANN, M. and MULLER, W. E. (1999): Hyperforin, a major
(22) antidepressant constituent of St. John’s Wort, inhibits serotonin uptake by
elevating free intracellular Na+1. J. Pharmacol. Exp. Ther. 290: 1363-1368.
(23) KRISHTAL, O.; LOZOVAYA, N.; FISUNOV, A.; TSINTSADZE, T.; PANKRATOV, Y.; KOPANIT-
(24) SA, M. and CHATTERJEE, S. S. (2001): Modulation of ion channels in rat neu-
(25) rons by the constituents of Hypericum perforatum. Pharmacopsychiatry 34:
(26) S74-S82.
(27) ECKERT, G. P.; KELLER, J. H.; JOURDAN, C.; KARAS, M.; VOLMER, D. A.; SCHUBERT-
(28) ZSILAVECZ, M. and MULLER, W. E. (2004): Hyperforin modifies neuronal mem-
(29) brane properties in vivo. Neurosci. Lett. 367: 139-143.
MARSH, W. L. and DAVIES, J. A. (2002): The involvement of sodium and cal-
(30) cium ions in the release of amino acid neurotransmitters from mouse corti-
cal slices elicited by hyperforin. Life Sci. 71: 2645-2655.
(31) ROZ, N. and REHAVI, M. (2003): Hyperforin inhibits vesicular uptake of mo-
noamines by dissipating pH gradient across synaptic vesicle membrane. Life
(32) Sci. 73: 461-470.
ROZ, N. and REHAVI, M. (2004): Hyperforin depletes synaptic vesicles content
(33) and induces compartmental redistribution of nerve ending monoamines. Life
Sci. 75: 2841-2850.
KIEWERT, C.; BUCHHOLZER, M. L.; HARTMANN, J.; CHATTERJEE, S. S. and KLEIN, J.
(2004): Stimulation of hippocampal acetylcholine release by hyperforin, a
constituent of St. John’s Wort. Neurosci. Lett. 364: 195-198.
MEDINA M. A.; MARTÍNEZ-POVEDA, B.; AMORES-SÁNCHEZ, M. I. and QUESADA, A. R.
(2006): Hyperforin: more than an antidepressant bioactive compound? Life
Sci. 79: 105-111.
GARCÍA DE VEAS, R.; SCHWEIGERER, L. and MEDINA, M. A. (1995): Matrix meta-
lloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in pae-
diatric tumour cells. Effects of tumour cell proliferation modulators on ge-
latinolytic activity. J. Cancer Res. Clin. Oncol. 121: 275-278.
GARCÍA DE VEAS, R.; SCHWEIGERER, L. and MEDINA, M. A. (1998): Modulation of
the proteolytic balance plasminogen activator/plasminogen activator inhibi-
tor by enhanced N-myc oncogene expression or application of genistein. Eur.
J. Cancer 34: 1736-1740.
FAJARDO, I.; QUESADA, A. R.; NÚÑEZ DE CASTRO, I.; SÁNCHEZ-JIMÉNEZ, F. and ME-
DINA, M. A. (1999): A comparative study of the effects of genistein and 2-
methoxyestradiol on the proteolytic balance and tumour cell proliferation.
Br. J. Cancer 80: 17-24.
RODRÍGUEZ-NIETO, S.; GONZÁLEZ-IRIARTE, M.; CARMONA, R.; MUÑOZ-CHÁPULI, R.;
MEDINA, M. A. and QUESADA, A. R. (2001): Antiangiogenic activity of aeroply-
sinin-1, a brominated compound isolated from a marine sponge. FASEB J.
10.1096/fj.01-0427fje.
CASTRO, M. A.; GONZÁLEZ-IRIARTE, M.; BARRERO, A. F.; SALVADOR-TORMO, N.;
MUÑOZ-CHÁPULI, R.; MEDINA, M. A. and QUESADA, A. R. (2004): Study of puupe-
henone and related compounds as inhibitors of angiogenesis. Int. J. Cancer
110: 31-38.
597
